drugset / Trial / NCT05823116
Continuous vs. Intermittent Infusion Vancomycin
Phase 4
Completed
37 enrolled
Aaron Cook
National Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Hospitalized adult participants prescribed vancomycin by their treating physician will be randomized to receive vancomycin via continuous or intermittent infusion and measures of kidney function and injury will be collected.
Timeline
- Start
- 2023-05-22
- Primary completion
- 2025-06-15
- Completion
- 2025-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vancomycin | Other / unclassified | 1 g | Intravenous |
Indications
No indication recorded.